199 related articles for article (PubMed ID: 21956459)
1. Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.
Tsai A; Liou YJ; Hong CJ; Wu CL; Tsai SJ; Bai YM
Neuromolecular Med; 2011 Dec; 13(4):328-33. PubMed ID: 21956459
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.
Hong CJ; Liou YJ; Bai YM; Chen TT; Wang YC; Tsai SJ
Pharmacogenet Genomics; 2010 Jun; 20(6):359-66. PubMed ID: 20375926
[TBL] [Abstract][Full Text] [Related]
3. TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
Huang HH; Wang YC; Wu CL; Hong CJ; Bai YM; Tsai SJ; Liou YJ
Neurosci Lett; 2011 Oct; 504(3):277-80. PubMed ID: 21967963
[TBL] [Abstract][Full Text] [Related]
4. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
[TBL] [Abstract][Full Text] [Related]
5. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
Bonaccorso S; Sodhi M; Li J; Bobo WV; Chen Y; Tumuklu M; Theleritis C; Jayathilake K; Meltzer HY
Bipolar Disord; 2015 Aug; 17(5):528-35. PubMed ID: 25874530
[TBL] [Abstract][Full Text] [Related]
6. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients.
Kuzman MR; Medved V; Bozina N; Hotujac L; Sain I; Bilusic H
Psychiatry Res; 2008 Sep; 160(3):308-15. PubMed ID: 18718676
[TBL] [Abstract][Full Text] [Related]
7. The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.
Zai GC; Zai CC; Chowdhury NI; Tiwari AK; Souza RP; Lieberman JA; Meltzer HY; Potkin SG; Müller DJ; Kennedy JL
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):96-101. PubMed ID: 22642961
[TBL] [Abstract][Full Text] [Related]
8. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
Houston JP; Kohler J; Bishop JR; Ellingrod VL; Ostbye KM; Zhao F; Conley RR; Poole Hoffmann V; Fijal BA
J Clin Psychiatry; 2012 Aug; 73(8):1077-86. PubMed ID: 22967772
[TBL] [Abstract][Full Text] [Related]
10. The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
Liu J; Wang P; Sun L; Guan X; Xiu M; Zhang X
Transl Psychiatry; 2021 Sep; 11(1):458. PubMed ID: 34482368
[TBL] [Abstract][Full Text] [Related]
11. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
[TBL] [Abstract][Full Text] [Related]
12. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.
Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ
Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157
[TBL] [Abstract][Full Text] [Related]
13. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
[TBL] [Abstract][Full Text] [Related]
14. Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls.
Fang H; Zhen YF; Liu XY; Xu G; Soares JC; Zhao J; Zhang XY
Int Clin Psychopharmacol; 2016 Nov; 31(6):353-7. PubMed ID: 27483421
[TBL] [Abstract][Full Text] [Related]
15. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
[TBL] [Abstract][Full Text] [Related]
16. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.
Gagliano SA; Tiwari AK; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Knight J; Müller DJ
Hum Psychopharmacol; 2014 Jul; 29(4):330-5. PubMed ID: 24737441
[TBL] [Abstract][Full Text] [Related]
18. Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.
Tiwari AK; Brandl EJ; Weber C; Likhodi O; Zai CC; Hahn MK; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
J Clin Psychopharmacol; 2013 Feb; 33(1):11-7. PubMed ID: 23277265
[TBL] [Abstract][Full Text] [Related]
19. Association of orexin receptor polymorphisms with antipsychotic-induced weight gain.
Tiwari AK; Brandl EJ; Zai CC; Goncalves VF; Chowdhury NI; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
World J Biol Psychiatry; 2016 Apr; 17(3):221-9. PubMed ID: 26447462
[TBL] [Abstract][Full Text] [Related]
20. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
